Safety Study of Colonoscopy Under Sedation (KALINAG)

Tolerance and Acceptability of Colonoscopy Under Sedation by an Equimolar Mixture of Oxygen and Nitrous Oxide. Comparison With General Anesthesia in a Randomized, Multicentric Study.

The aim of this study was to compare the analgesia provided by nitrous oxide/oxygen sedation or general anesthesia for colonoscopy

Study Overview

Status

Terminated

Detailed Description

The purpose of this protocol is to compare two methods of analgesia/sedation for colonoscopy. Sedation and analgesia induced by a 50% nitrous oxide/oxygen mixture could sufficient to allow the practice of colonoscopy instead of general anesthesia which is accompanied with certain risks and post procedure drowsiness.

Study Type

Interventional

Enrollment (Actual)

220

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75004
        • Hotel Dieu Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patient referred for colonoscopy with general anesthesia
  2. Age above 18 et below 75 year
  3. Patient who gave an informed consent

Exclusion Criteria:

  1. Age below 18 ou above 75
  2. Need for gastroscopy in the same procedure than colonoscopy
  3. History of surgery wih resection more extended than half of the colon
  4. Dementia with autonomy loss or psychiatric disorder non controlled by therapeutic
  5. Severe congestive heart failure or evolutive heart ischemia
  6. Recent cerebral stroke
  7. Hemodynamic instability
  8. Respiratory failure, severe chronic obstructive pulmonary (including asthma) or progressive pneumothorax
  9. Hepatic failure (Child-Pugh score> 9)
  10. Terminal renal failure 11 Hematopoietic disorders

12. Pathology with expected survival shorter than the duration of the study and cancer excepted basal cell carcinoma of the skin 13. Alcohol consumption higher than 100 gr per day 14. Pregnancy or breastfeeding at the inclusion period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MEOPA
MEOPA : equimolar nitrous oxide/oxygen mixture
anaesthetic gaz inhalation
Other Names:
  • anaesthetic gaz inhalation
Active Comparator: General anesthesia
Gold standard
Anaesthetic intravenous route
Other Names:
  • Anaesthetic intravenous route

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of patients who have well tolerated the colonoscopy as assessed by visual analogic scale (>75/100)
Time Frame: Immediately after the colonoscopy
Immediately after the colonoscopy
The mean grade of patient anxiety before endoscopy
Time Frame: After the colonoscopy
The mean grade of patient anxiety before endoscopy
After the colonoscopy

Secondary Outcome Measures

Outcome Measure
Time Frame
The mean tolerability of the colonoscopy between the group with sedation by nitrous oxide/oxygen mixture and the group with anesthesia
Time Frame: after the colonoscopy
after the colonoscopy
The mean pain intensity during the procedure on a visual analogic scale
Time Frame: after the colonoscopy
after the colonoscopy
The mean patient satisfaction on a visual analogic scale.
Time Frame: after the colonoscopy
after the colonoscopy
The percentage of patients who agree to repeat the procedure in similar circumstances.
Time Frame: after the colonoscopy
after the colonoscopy
The grade of difficulty of the colonoscopy evaluated by the endoscopist
Time Frame: After the colonoscopy
After the colonoscopy
The mean duration of the endoscopy
Time Frame: After the colonoscopy
After the colonoscopy
The percentage of caecum intubation
Time Frame: After the colonoscopy
After the colonoscopy
The percentage of ileal intubation
Time Frame: After the colonoscopy
After the colonoscopy
The opinion of the endoscopist on the tolerance of the colonoscopy
Time Frame: After the colonoscopy
After the colonoscopy
The time to hospital discharge
Time Frame: After the issue of the colonoscopy
After the issue of the colonoscopy
The Aldrete's score at the hospital discharge
Time Frame: After the colonoscopy
After the colonoscopy
The number of patient who have refused the inclusion
Time Frame: After the issue of the colonoscopy
After the issue of the colonoscopy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dominique Lamarque, MD, PhD, Assistance Publique - Hôpitaux de Paris

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2009

Primary Completion (Actual)

January 1, 2011

Study Completion (Actual)

January 1, 2011

Study Registration Dates

First Submitted

June 29, 2009

First Submitted That Met QC Criteria

June 29, 2009

First Posted (Estimate)

June 30, 2009

Study Record Updates

Last Update Posted (Estimate)

April 6, 2011

Last Update Submitted That Met QC Criteria

April 5, 2011

Last Verified

April 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • P060240

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colonoscopy Procedure

Clinical Trials on MEOPA

3
Subscribe